Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Paper of the day - ACE inhibition improves mobility

ACE-inhibitors may directly improve the exercise capacity and quality of life of elderly people with mobility problems but no heart failure, according to a study published today.

The double-blind, randomised study looked at the effects of perindopril in 130 people over 65 with mobility or functional impairment but no clinical diagnosis of heart failure. After 20 weeks, there was a mean difference of 31.4m in the distance that the perindopril-treated group could walk in 6 minutes, compared with the placebo group.

This improvement in exercise capacity with ACE inhibition is similair to the improvement seen after six months of exercise training. This may be due to an improvement in cardiac function, but also could be the result of a direct effect on muscle function, said the authors.

The increased mobility of the ACE-inhibitor treated participants was associated with a significant impact on quality of life. A decline in health-related quality of life was seen over time in the placebo group, but was maintained in the ACE-inhibitor treated group.

The authors said that the improvements in mobility and quality of life in this study should provide further encouragement for clinicians deliberating over the use of ACE inhibitors in elderly people for existing indications.

Canadian Medical Association Journal 2007;177(8):867-874

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say